Myriad Genetics can hold patents on the BRAC1 and BRAC2 oncogenes, but not on tests comparing DNA sequences.
The Nutshell
Daily News Roundup
Most Recent
A former manager at Genentech claims the company bypassed ethical and clinical guidelines in order to rush a promising drug through clinical trials.
Patent expirations of one HIV drugs will make the disease cheaper—but also more cumbersome—to treat.
A researcher from the John Wayne Cancer Institute has settled his scientific misconduct case with the Office of Research Integrity.
Australian trout are susceptible to skin cancer, according to a new study—the first evidence that wild fish can be afflicted by the disease.
The National Institutes of Health will fund 17 projects developing lab-on-a-chip applications to improve drug screening.
An approved cancer therapeutic makes hiding HIV susceptible to antiviral therapy.
The first full computer model of a single-celled organism mimics the bacterium’s behaviors and paves the way to more complete disease models.
Publicly accessible databases now store nearly 1 million gene-expression datasets, giving researchers a robust resource for discovery.
Researchers engineer a member of the insect's intestinal flora to help thwart the malaria parasite before it can infect new hosts.
Subjects
- cell & molecular biology
- clinical trials
- culture
- disease/medicine
- ecology
- evolution
- funding
- genetics & genomics
- NIH
- policy
Sub Categories
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
